CLOSE X
GO

Tata India Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
27.32 -0.23(-0.84%) NAV as on 10 Mar 2025
-6.94 % 1 M
8.84 % 1 Y
18.04 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.19

As on 28 Feb, 2025
age-icon Age :

9 yrs 2 m

Since 28 12 ,2015
exit_load Exit Load :

0.25%

aum AUM :

1,103.99 Crs

lock_in Lock-in :

0.25% on or before 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

5.64

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Meeta Shetty,Rajat Srivastava

LATEST ASSET & PORTFOLIO ALLOCATION

as on Feb 28 ,2025
Others 1.94 %
Equity 98.06 %

TOP HOLDINGS

Sun Pharmaceutical Industries...11.61 %
Dr. Reddy's Laboratories Ltd.7.23 %
Aurobindo Pharma Ltd.7.10 %
Cipla Ltd.6.25 %
Lupin Ltd.6.22 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs73.56
Hospital & Healthcare Services20.22
Business Support2.35
Fertilizers0.91
BPO/ITeS0.68
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 07-Mar-2025)14.7317.1815.8825.0627.55
Net Assets(Rs Crores) (as on 07-Mar-2025) 435.03 553.33 493.44 878.70 1103.99
Scheme Returns(%)(Absolute)67.2416.04-7.3157.468.70
B'mark Returns(%)(Absolute)NANANANANA
Category Rank49/7541/7567/7619/9016/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity27.32-0.23(-0.84%)NAV As on 10 Mar, 202528-Dec-2015Inception Date1,103.99AUM In Cr.8.84%1Y18.04%3Y23.10%5Y11.53%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity34.86-0.32(-0.91%)NAV As on 10 Mar, 202513-Jul-2018Inception Date4,611.47AUM In Cr.15.35%1Y22.64%3Y27.19%5Y20.61%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity393.15-4.11(-1.03%)NAV As on 10 Mar, 202514-Jul-1999Inception Date3,312.89AUM In Cr.16.42%1Y22.32%3Y25.80%5Y16.11%Since Inception
Nippon India Pharma Fund(G)Very HighEquity465.31-2.67(-0.57%)NAV As on 10 Mar, 202505-Jun-2004Inception Date7,637.04AUM In Cr.8.62%1Y18.26%3Y24.61%5Y20.30%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors